Tanja Holopainen
- Oncology top 2%
- Lymphatic System and Diseases 13
- Vascular Tumors and Angiosarcomas 6
- Cancer Cells and Metastasis 2
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism 3
- Molecular Biology top 10%
- Angiogenesis and VEGF in Cancer 17
- Physiology top 10%
- Immunology and Allergy top 10%
- Cell Adhesion Molecules Research 3
-
- Vascular Malformations and Hemangiomas 2
-
- Cardiac Fibrosis and Remodeling 2
- Co-authors
- Kari AlitaloSeppo Ylä‐HerttualaMichael JeltschTuomas TammelaAndrey AnisimovAnne SaaristoTakashi TakahashiDenis Tvorogov
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Circulation (3 papers)Journal of Clinical Investigation (1 paper)
- Partner nations
- FinlandUnited StatesSouth Korea
In The Last Decade
Tanja Holopainen
27 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 94
- Oncology 1.3k
- Cancer Research 282
- Molecular Biology 1.2k
- Physiology 357
- Immunology and Allergy 71
Countries citing papers authored by Tanja Holopainen
This map shows the geographic impact of Tanja Holopainen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tanja Holopainen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tanja Holopainen more than expected).
Fields of papers citing papers by Tanja Holopainen
This network shows the impact of papers produced by Tanja Holopainen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tanja Holopainen. The network helps show where Tanja Holopainen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tanja Holopainen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 47 | |
| 2 | 2016 | 12 | |
| 3 | 2015 | 58 | |
| 4 | 2015 | 14 | |
| 5 | 2014 | 178 | |
| 6 | 2014 | 97 | |
| 7 | 2014 | 61 | |
| 8 | 2014 | 65 | |
| 9 | 2013 | 48 | |
| 10 | 2013 | 46 | |
| 11 | 2012 | 27 | |
| 12 | 2012 | 6 | |
| 13 | 2011 | 35 | |
| 14 | 2010 | 99 | |
| 15 | 2009 | 44 | |
| 16 | 2008 | 95 | |
| 17 | 2007 | 184 | |
| 18 | Inhibition of VEGF-C-induced VEGFR-3 activity and lymphatic endothelial cell function by the tyrosine kinase inhibitor AZD2171 | 2007 | 1 |
| 19 | 2007 | 290 | |
| 20 | 1965 | 6 |
About Tanja Holopainen
Tanja Holopainen is a scholar working on Oncology, Immunology and Allergy and Molecular Biology, having authored 27 papers that have together received 2.1k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (17 papers), Lymphatic System and Diseases (13 papers), Vascular Tumors and Angiosarcomas (6 papers), Cancer, Hypoxia, and Metabolism (3 papers), Cell Adhesion Molecules Research (3 papers), Vascular Malformations and Hemangiomas (2 papers), Cancer Cells and Metastasis (2 papers) and Cardiac Fibrosis and Remodeling (2 papers). The work is most often cited by research in Oncology (1.3k citations), Cancer Research (282 citations) and Molecular Biology (1.2k citations). Tanja Holopainen has collaborated with scholars based in Finland, United States and South Korea. Frequent co-authors include Kari Alitalo, Seppo Ylä‐Herttuala, Michael Jeltsch, Tuomas Tammela, Andrey Anisimov, Anne Saaristo, Takashi Takahashi, Denis Tvorogov, Yulong He and Tatiana V. Petrova. Their work appears in journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.